300 related articles for article (PubMed ID: 29298978)
1. A machine learning approach to integrate big data for precision medicine in acute myeloid leukemia.
Lee SI; Celik S; Logsdon BA; Lundberg SM; Martins TJ; Oehler VG; Estey EH; Miller CP; Chien S; Dai J; Saxena A; Blau CA; Becker PS
Nat Commun; 2018 Jan; 9(1):42. PubMed ID: 29298978
[TBL] [Abstract][Full Text] [Related]
2. Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposide.
Turk S; Turk C; Akbar MW; Kucukkaraduman B; Isbilen M; Demirkol Canli S; Malkan UY; Okay M; Ucar G; Sayinalp N; Haznedaroglu IC; Gure AO
PLoS One; 2020; 15(11):e0242497. PubMed ID: 33237942
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Identification and Characterization of Novel Factors Conferring Resistance to Topoisomerase II Poisons in Cancer.
Wijdeven RH; Pang B; van der Zanden SY; Qiao X; Blomen V; Hoogstraat M; Lips EH; Janssen L; Wessels L; Brummelkamp TR; Neefjes J
Cancer Res; 2015 Oct; 75(19):4176-87. PubMed ID: 26260527
[TBL] [Abstract][Full Text] [Related]
4. Personalized therapy for acute myeloid leukemia.
Hourigan CS; Karp JE
Cancer Discov; 2013 Dec; 3(12):1336-8. PubMed ID: 24327695
[TBL] [Abstract][Full Text] [Related]
5. Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.
Pemovska T; Kontro M; Yadav B; Edgren H; Eldfors S; Szwajda A; Almusa H; Bespalov MM; Ellonen P; Elonen E; Gjertsen BT; Karjalainen R; Kulesskiy E; Lagström S; Lehto A; Lepistö M; Lundán T; Majumder MM; Marti JM; Mattila P; Murumägi A; Mustjoki S; Palva A; Parsons A; Pirttinen T; Rämet ME; Suvela M; Turunen L; Västrik I; Wolf M; Knowles J; Aittokallio T; Heckman CA; Porkka K; Kallioniemi O; Wennerberg K
Cancer Discov; 2013 Dec; 3(12):1416-29. PubMed ID: 24056683
[TBL] [Abstract][Full Text] [Related]
6. Pim kinase inhibition sensitizes FLT3-ITD acute myeloid leukemia cells to topoisomerase 2 inhibitors through increased DNA damage and oxidative stress.
Doshi KA; Trotta R; Natarajan K; Rassool FV; Tron AE; Huszar D; Perrotti D; Baer MR
Oncotarget; 2016 Jul; 7(30):48280-48295. PubMed ID: 27374090
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acute myeloid leukemia in the next decade - Towards real-time functional testing and personalized medicine.
Lam SS; He AB; Leung AY
Blood Rev; 2017 Nov; 31(6):418-425. PubMed ID: 28797519
[TBL] [Abstract][Full Text] [Related]
8. Integrated pan-cancer gene expression and drug sensitivity analysis reveals SLFN11 mRNA as a solid tumor biomarker predictive of sensitivity to DNA-damaging chemotherapy.
Shee K; Wells JD; Jiang A; Miller TW
PLoS One; 2019; 14(11):e0224267. PubMed ID: 31682620
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AML.
Nguyen NHK; Rafiee R; Tagmount A; Sobh A; Loguinov A; de Jesus Sosa AK; Elsayed AH; Gbadamosi M; Seligson N; Cogle CR; Rubnitz J; Ribeiro R; Downing J; Cao X; Pounds SB; Vulpe CD; Lamba JK
Blood Adv; 2023 May; 7(9):1769-1783. PubMed ID: 36111891
[TBL] [Abstract][Full Text] [Related]
10. [Research Progress on the Role of Chromatin Remodeling Factor BRG1 in Acute Myeloid Leukemia].
Gao S; Xu XJ; Zhang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Jun; 24(3):930-3. PubMed ID: 27342536
[TBL] [Abstract][Full Text] [Related]
11. Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia.
Qin G; Dai J; Chien S; Martins TJ; Loera B; Nguyen QH; Oakes ML; Tercan B; Aguilar B; Hagen L; McCune J; Gelinas R; Monnat RJ; Shmulevich I; Becker PS
Clin Cancer Res; 2024 Jun; 30(12):2659-2671. PubMed ID: 38619278
[TBL] [Abstract][Full Text] [Related]
12. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
[TBL] [Abstract][Full Text] [Related]
13. Amonafide: a future in treatment of resistant and secondary acute myeloid leukemia?
Freeman CL; Swords R; Giles FJ
Expert Rev Hematol; 2012 Feb; 5(1):17-26. PubMed ID: 22272701
[TBL] [Abstract][Full Text] [Related]
14. Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.
Bret C; Viziteu E; Kassambara A; Moreaux J
Expert Rev Hematol; 2016; 9(4):351-60. PubMed ID: 26761438
[TBL] [Abstract][Full Text] [Related]
15. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Laing AA; Harrison CJ; Gibson BES; Keeshan K
Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
[TBL] [Abstract][Full Text] [Related]
16. Low expression of GFI-1 Gene is associated with Panobinostat-resistance in acute myeloid leukemia through influencing the level of HO-1.
Cheng B; Tang S; Zhe N; Ma D; Yu K; Wei D; Zhou Z; Lu T; Wang J; Fang Q
Biomed Pharmacother; 2018 Apr; 100():509-520. PubMed ID: 29494986
[TBL] [Abstract][Full Text] [Related]
17. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
[TBL] [Abstract][Full Text] [Related]
18. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
[TBL] [Abstract][Full Text] [Related]
19. Genomic and transcriptomic profiles and in vitro resistance to mitoxantrone and idarubicin in pediatric acute leukemias.
Laskowska J; Lewandowska-Bieniek J; Szczepanek J; Styczyński J; Tretyn A
J Gene Med; 2016 Aug; 18(8):165-79. PubMed ID: 27280600
[TBL] [Abstract][Full Text] [Related]
20. miR-181b increases drug sensitivity in acute myeloid leukemia via targeting HMGB1 and Mcl-1.
Lu F; Zhang J; Ji M; Li P; Du Y; Wang H; Zang S; Ma D; Sun X; Ji C
Int J Oncol; 2014 Jul; 45(1):383-92. PubMed ID: 24756163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
